Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | -2.40% | -3.79% | -41.33% |
May. 09 | Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Business Summary
Number of employees: 31
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Water Filtration
99.1
%
| 10 | 100.0 % | 14 | 99.1 % | +41.45% |
Other
0.7
%
| - | - | 0 | 0.7 % | - |
Royalty
0.2
%
| - | - | 0 | 0.2 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 10 | 100.0 % | 14 | 100.0 % | +42.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 23-03-30 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | Oct. 31 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Michael Milman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Judy Mazzini
AUD | Comptroller/Controller/Auditor | - | 17-05-31 |
Devorah Serkin
PRN | Corporate Officer/Principal | - | - |
Brianne McGuire
SAM | Sales & Marketing | - | - |
Vashone Thomas
HRO | Human Resources Officer | - | 17-12-31 |
Anthony Robinson
PRN | Corporate Officer/Principal | - | 20-03-24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 07-09-18 |
Oliver Spandow
BRD | Director/Board Member | 52 | 18-08-09 |
Alisa Lask
BRD | Director/Board Member | 53 | 19-02-07 |
Joe Harris
BRD | Director/Board Member | 56 | 22-09-07 |
Robert Banks
CEO | Chief Executive Officer | 49 | 23-03-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,544,139 | 9,204,793 ( 87.30 %) | 0 | 87.30 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.33% | 21.4M | |
+7.76% | 8.48B | |
+34.76% | 2.25B | |
-4.92% | 1.13B | |
+38.07% | 978M | |
+20.89% | 722M | |
+22.10% | 605M | |
+4.75% | 606M | |
-26.16% | 519M | |
-26.92% | 441M |
- Stock Market
- Equities
- NEPH Stock
- Company Nephros, Inc.